CoChat

The Critical Role of Oxidative Stress in Sarcopenic Obesity

Open access
Gonzalez, Andrea, Simon, Felipe, Achiardi, Oscar, Vilos, Cristian, Cabrera, Daniel, Cabello-Verrugio, Claudio · 2021 · Oxidative Medicine and Cellular Longevity

The DOI matches its Crossref record; 161 of the 161 references it cites were found in a registry or an index; 62 of the 321 sources its claims cite were checked for support.

Abstract

Sarcopenic obesity (SO) is a combination of obesity and sarcopenia that primarily develops in older people. Patients with SO have high fat mass, low muscle mass, low muscle strength, and low physical function. SO relates to metabolic syndrome and an increased risk of morbimortality. The prevalence of SO varies because of lacking consensus criteria regarding its definition and the methodological difficulty in diagnosing sarcopenia and obesity. SO includes systemic alterations such as insulin resistance, increased proinflammatory cytokines, age‐associated hormonal changes, and decreased physical activity at pathophysiological levels. Interestingly, these alterations are influenced by oxidative stress, which is a critical factor in altering muscle function and the generation of metabolic dysfunctions. Thus, oxidative stress in SO alters muscle mass, the signaling pathways that control it, satellite cell functions, and mitochondrial and endoplasmic reticulum activities. Considering this background, our objectives in this review are to describe SO as a highly prevalent condition and look at the role of oxidative stress in SO pathophysiology.

Overview

CoChat Summary

TL;DR

This review argues that oxidative stress is a central mechanism in sarcopenic obesity (SO) pathophysiology, affecting skeletal muscle, liver, and adipose tissue through mitochondrial dysfunction, endoplasmic reticulum stress, and altered muscle mass control pathways. It also emphasizes that SO is highly prevalent but remains difficult to define and diagnose because of inconsistent criteria.

Key findings

  • SO prevalence varies between 2% and 85%, depending on differences in SO definitions, studied populations, and diagnostic criteria/methods for obesity and sarcopenia; there are no internationally standardized criteria for diagnosing SO.
  • Oxidative stress in SO is linked to mitochondrial dysfunction, ER stress, and imbalance between anabolic and catabolic muscle mass pathways; ROS activate the ubiquitin-proteasome system (including MuRF1 and atrogin-1), NF-κB, and impair PI3K/Akt/mTOR signaling, while also dysregulating satellite cell function.
  • In patients, circulating oxidative stress markers such as GSH, GSSG, MDA, and 4-HNE increase in elderly patients with SO compared with nonsarcopenic nonobese, sarcopenic nonobese, and nonsarcopenic obese patients; systemic oxidative stress is also associated with muscle mass decline in elderly patients with obesity and T2DM.
  • Animal-model evidence includes resveratrol preventing SO features via the PKA/LKB1/AMPK pathway, tocotrienols and green tea polyphenols increasing muscle mass, cross-sectional area, and mitochondrial enzyme activity, and Lactobacillus paracasei PS23 attenuating age-related muscle loss with higher mitochondrial function and antioxidant enzymes and lower inflammatory cytokines and oxidative stress.

Methods

  • Narrative review describing SO as a highly prevalent condition and examining the role of oxidative stress in its pathophysiology.
  • Synthesizes literature on SO definitions, diagnosis, general characteristics, pathophysiology, oxidative stress mechanisms, and redox-dependent mechanisms from animal models and patients.
  • No systematic review, meta-analysis, primary data collection, sample size, or formal quantitative analysis is reported.

Limitations

  • The paper states that there is no consensus on SO evaluation methods and definitions, so results across investigations are highly variable and difficult to compare; diagnostic methods such as CT, DXA, MRI, and BIA are complex, costly, and less feasible for large-scale research or clinical practice.
  • The paper states that there is limited evidence clarifying the mechanisms involved in the redox-dependent effect of SO in human and animal models, and that most animal research tests antiobesity, antiaging, or antioxidant agents rather than directly elucidating how oxidative stress favors SO.
  • Evident from the text: as a narrative review, it does not report a systematic search strategy, study quality appraisal, or quantitative synthesis, so its conclusions rely on the cited literature rather than new primary data.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1155/2021/4493817

Cites

161 of 161 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Figure 1 Pathophysiology and consequences of sarcopenic obesity. Sarcopenic obesity (SO) is a combination of obesity and sarcopenia in older people. Obesity and sarcopenia share pathological alterations such as insulin resistance, increased proinflammatory cytokines, age-associated hormonal changes, decreased physical activity, oxidative stress, and liver, adipose, and skeletal muscle dysfunction. Increased body fat mass, especially in the abdominal area (visceral fat), is characteristic of obesity and aging and produces an accumulation of adipose tissue in the liver (liver steatosis) and skeletal muscle (myosteatosis), with the consequent induction of IR, lipotoxicity (Lptx), inflammation, and oxidative stress (Os). Adipocyte hypertrophy induces a state of chronic systemic inflammation characterized by decreased adiponectin and elevated levels of C-reactive protein (CRP), leptin, tumor necrosis factor-α (TNF-α), and interleukin 6 (IL-6). Also, obesity and aging produce hormonal changes such as a decrease in growth hormone (GH), testosterone, estrogen, IGF-1, and adiponectin and an increase in myostatin. Finally, physical inactivity is a common feature of obesity and aging, affecting respiratory, osteoarticular, and neuromuscular levels, inducing loss of physical function. The consequences of sarcopenic obesity are a high risk of fractures, frailty, hospitalization, morbidity and mortality, loss of independence, and decreased quality of life. Abbreviations: SO: sarcopenic obesity; Lptx: lipotoxicity; Os: oxidative stress; CRP: C-reactive protein; TNF-α: tumor necrosis factor-α; IL-6: interleukin 6; GH: growth hormone; IGF-1: insulin-like growth factor 1.
Figure 1 Pathophysiology and consequences of sarcopenic obesity. Sarcopenic obesity (SO) is a combination of obesity and sarcopenia in older people. Obesity and sarcopenia share pathological alterations such as insulin resistance, increased proinflammatory cytokines, age-associated hormonal changes, decreased physical activity, oxidative stress, and liver, adipose, and skeletal muscle dysfunction. Increased body fat mass, especially in the abdominal area (visceral fat), is characteristic of obesity and aging and produces an accumulation of adipose tissue in the liver (liver steatosis) and skeletal muscle (myosteatosis), with the consequent induction of IR, lipotoxicity (Lptx), inflammation, and oxidative stress (Os). Adipocyte hypertrophy induces a state of chronic systemic inflammation characterized by decreased adiponectin and elevated levels of C-reactive protein (CRP), leptin, tumor necrosis factor-α (TNF-α), and interleukin 6 (IL-6). Also, obesity and aging produce hormonal changes such as a decrease in growth hormone (GH), testosterone, estrogen, IGF-1, and adiponectin and an increase in myostatin. Finally, physical inactivity is a common feature of obesity and aging, affecting respiratory, osteoarticular, and neuromuscular levels, inducing loss of physical function. The consequences of sarcopenic obesity are a high risk of fractures, frailty, hospitalization, morbidity and mortality, loss of independence, and decreased quality of life. Abbreviations: SO: sarcopenic obesity; Lptx: lipotoxicity; Os: oxidative stress; CRP: C-reactive protein; TNF-α: tumor necrosis factor-α; IL-6: interleukin 6; GH: growth hormone; IGF-1: insulin-like growth factor 1.CC BY · PubMed Central
Figure 2 Oxidative stress in sarcopenic obesity. In older people, oxidative stress (Os) favors sarcopenia and obesity through mitochondrial dysfunction, endoplasmic reticulum (ER) stress, and imbalance in muscle mass control. Mitochondrial dysfunction in sarcopenia is induced by Os due to mitochondrial DNA damage and impaired mechanisms for repairing DNA ability, impaired capacity to remove dysfunctional mitochondria, decreased mitochondrial quantity and quality, and impaired capacity to generate ATP to activate the apoptotic pathways. ER stress and Os are caused by an increase in adipose tissue, chronic inflammation, and insulin resistance, all of which are characteristics of obesity and aging. ER stress induces Os, favoring unfolded protein response (UPR) overactivation, imbalance in calcium homeostasis, increased protein aggregation, and decreased protein synthesis. Imbalance in muscle mass control occurs because Os increases the catabolic activity and decreases the anabolic pathway in muscle mass control. Os reduces protein synthesis due to the reduced activity in phosphatidylinositol 3-kinase (PI3K)/serine-threonine kinase (Akt)/mammalian target of rapamycin (mTOR). Os increases the activity of the ubiquitin-proteasome system (UPS) and activates muscle proteases such as caspases and calpains. Finally, due to Os, satellite cells' quantity and regenerative function decline with age and obesity. Mitochondrial dysfunction, ER stress, and imbalance in the muscle mass control pathways induce lipotoxicity (Lptx), chronic inflammation, IR, and loss of muscle mass, affecting physical function and independence in sarcopenic obesity. Abbreviations: Os: oxidative stress; ER: endoplasmic reticulum; UPR: unfolded protein response; PI3K: phosphatidylinositol 3-kinase; Akt: serine-threonine kinase; mTOR: mammalian target of rapamycin; UPS: ubiquitin-proteasome system (UPS); Lptx: lipotoxicity.
Figure 2 Oxidative stress in sarcopenic obesity. In older people, oxidative stress (Os) favors sarcopenia and obesity through mitochondrial dysfunction, endoplasmic reticulum (ER) stress, and imbalance in muscle mass control. Mitochondrial dysfunction in sarcopenia is induced by Os due to mitochondrial DNA damage and impaired mechanisms for repairing DNA ability, impaired capacity to remove dysfunctional mitochondria, decreased mitochondrial quantity and quality, and impaired capacity to generate ATP to activate the apoptotic pathways. ER stress and Os are caused by an increase in adipose tissue, chronic inflammation, and insulin resistance, all of which are characteristics of obesity and aging. ER stress induces Os, favoring unfolded protein response (UPR) overactivation, imbalance in calcium homeostasis, increased protein aggregation, and decreased protein synthesis. Imbalance in muscle mass control occurs because Os increases the catabolic activity and decreases the anabolic pathway in muscle mass control. Os reduces protein synthesis due to the reduced activity in phosphatidylinositol 3-kinase (PI3K)/serine-threonine kinase (Akt)/mammalian target of rapamycin (mTOR). Os increases the activity of the ubiquitin-proteasome system (UPS) and activates muscle proteases such as caspases and calpains. Finally, due to Os, satellite cells' quantity and regenerative function decline with age and obesity. Mitochondrial dysfunction, ER stress, and imbalance in the muscle mass control pathways induce lipotoxicity (Lptx), chronic inflammation, IR, and loss of muscle mass, affecting physical function and independence in sarcopenic obesity. Abbreviations: Os: oxidative stress; ER: endoplasmic reticulum; UPR: unfolded protein response; PI3K: phosphatidylinositol 3-kinase; Akt: serine-threonine kinase; mTOR: mammalian target of rapamycin; UPS: ubiquitin-proteasome system (UPS); Lptx: lipotoxicity.CC BY · PubMed Central

Verification

Claims the paper makes

26 Valid · 2 Not valid · 76 Not checked · 15 Own results and interpretations

31 more claims · 4 with their cited sources checked

Create a free account to see all 119 claims and to verify the 259 references still open.

See all claims — free account
  • Probably not a substantial claim. 16
  • It may state two separate claims as one. 78

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 161 references

Cited by

See all 93

Metadata

Authors
Gonzalez, A., Simon, F., Achiardi, O., Vilos, C., Cabrera, D., & Cabello-Verrugio, C.
Affiliations
  • Pontificia Universidad Católica de Valparaíso (CL)
  • Pontificia Universidad Católica de Chile (CL)
Venue
Oxidative Medicine and Cellular Longevity
Publisher
Wiley
Published
2021-01
Volume
2021
Issue
1
Pages
4493817-4493817
ISSN
  • 1942-0994 (ISSN-L)
  • 1942-0900
OpenAlex
W3205252850
Cited by
79
References
160
Citations by year
2026: 20 · 2025: 25 · 2024: 14 · 2023: 17 · 2022: 3
FWCI
1.13
Type
journal article
Language
en
Open access
Locations
  • Oxidative Medicine and Cellular Longevity (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Universidad de Chile (submittedVersion, cc-by-nc-nd)
Funders
  • CEDENNA (AFB180001, P09-016-F, 1211879, 1201147, 1201039, 1200944)
  • Millennium Institute on Immunology and Immunotherapy (AFB180001, P09-016-F, 1211879, 1201147, 1201039, 1200944)
  • National Fund for Science and Technological Development (AFB180001, P09-016-F, 1211879, 1201147, 1201039, 1200944)
Topics
  • Health Sciences › Medicine › Physiology (medical) › Nutrition and Health in Aging
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Muscle Physiology and Disorders
  • Health Sciences › Medicine › Physiology (medical) › Exercise and Physiological Responses
Keywords
sarcopenic obesity, oxidative stress, sarcopenia, obesity, muscle mass, muscle strength, insulin resistance, inflammatory cytokines, satellite cells, mitochondrial dysfunction, endoplasmic reticulum stress, metabolic syndrome, aging, physical activity
MeSH terms
Humans, Middle Aged, Obesity, Oxidative Stress, Sarcopenia

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-05, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-05 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol and qwen3.8-omni-flash).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.